InterCure Ltd.
INCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -32.8% | -8.5% | 76.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 12.7% | 29.6% | 39.9% | 41.5% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -21.5% | -6.7% | 18.1% | 14.2% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -28.4% | -17.4% | 11.5% | 2.1% |
| EPS Diluted | -1.42 | -1.36 | 0.99 | 0.11 |
| % Growth | -4.4% | -237.4% | 800% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |